Is there a healthy foreign born effect for childhood obesity in the United States?

Nan Li1, Donna Strobino, Saifuddin Ahmed

  • 1Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA. nli@jhsph.harvard.edu

Insights

Having a foreign-born mother does not protect against early childhood obesity. Factors like low birth weight, maternal pre-pregnancy weight, and pregnancy weight gain are protective. Focus on maternal and infant health before and during pregnancy to combat childhood obesity.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Early childhood obesity is a growing public health concern with complex contributing factors.
  • Understanding protective factors is crucial for developing effective prevention strategies.
  • The role of maternal birthplace in childhood obesity risk requires further investigation.

Purpose of the Study:

  • To identify factors associated with early childhood obesity.
  • To determine if having a foreign-born mother is protective against childhood obesity.
  • To inform public health interventions for obesity prevention.

Main Methods:

  • Utilized data from the Early Childhood Longitudinal Study-Birth Cohort, including parent interviews and direct child assessments.
  • Analyzed anthropometric measures (weight, height, length) at 9 months and 4 years.
  • Defined overweight and obesity using standardized percentile cutoffs (95th percentile).

Main Results:

  • Prevalence of overweight/obesity was 15.4% at 9 months and 18.0% at 4 years.
  • Foreign-born maternal status was not associated with childhood overweight/obesity.
  • Protective factors included low birth weight, maternal pre-pregnancy weight, pregnancy weight gain, safe neighborhoods, and breastfeeding.

Conclusions:

  • Maternal birthplace is not a protective factor against early childhood obesity.
  • Maternal health prior to conception and during the perinatal period are critical for preventing childhood obesity.
  • Targeted interventions focusing on maternal health are essential for addressing childhood obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...